Skip to main content

Table 5 Comparison of metabolic indexes between the two groups

From: A nonrandomized controlled trial of individualized exercise prescription combined with remote exercise management in patients who are overweight or obese

 

Experimental group (n = 55)

Control group (n = 34)

For delta indicators

Before intervention t−1

After intervention t0

Delta changes

Before intervention t−1

After intervention t0

Delta changes

t

P

UA (μmol/L)

361.96 ± 96.55

357.56 ± 103.13

−9.75 ± 19.68

322.12 ± 90.45

307.96 ± 91.46

−1.31 ± 12.37

2.239

0.028

TC (mmol/L)

4.52 ± 0.71

4.40 ± 0.72

−0.11 ± 0.40

4.76 ± 0.81

4.95 ± 0.92

−0.11 ± 0.59

2.953

0.004

TG (mmol/L)

1.37 ± 0.65

1.31 ± 0.67

−0.07 ± 0.64

1.57 ± 1.42

1.47 ± 1.15

−0.11 ± 0.59

−0.319

0.750

LDL-C (mmol/L)

1.20 ± 0.19

1.23 ± 0.21

0.02 ± 0.13

1.29 ± 0.21

1.32 ± 0.24

0.04 ± 0.23

0.308

0.705

HDL-C (mmol/L)

2.77 ± 0.67

2.79 ± 0.68

0.03 ± 0.39

2.87 ± 0.66

3.01 ± 0.72

0.14 ± 0.40

1.286

0.202

HbA1c (%)

5.60 ± 0.45

5.63 ± 0.45

0.03 ± 0.37

5.58 ± 0.38

5.49 ± 0.36

−0.09 ± 0.26

−1.701

0.092

FBG (mmol/L)

5.21 ± 0.62

4.92 ± 0.5

−0.28 ± 0.52

5.07 ± 0.47

4.94 ± 0.74

−0.13 ± 0.69

1.229

0.222

FI (μU/mL)

11.16 ± 5.34

8.80 ± 5.60

−2.36 ± 5.20

11.45 ± 5.52

12.67 ± 7.59

1.22 ± 7.34

2.688

0.009

HOMA-IR

2.59 ± 1.40

1.97 ± 1.33

−0.62 ± 1.25

2.58 ± 1.25

2.72 ± 1.61

0.14 ± 1.83

2.327

0.022

  1. UA uric acid, TC total cholesterol, TG triglycerides, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, HbA1c hemoglobin A1c, FBG fasting blood glucose, FI fasting insulin, HOMA-IR homeostatic model assessment of insulin resistance